Comments on: (Anxiety Disorder News) EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3 Clinical Trial at 47th Annual NCDEU Meeting (Business Wire via Yahoo! Finance)

Comments on: (Anxiety Disorder News) EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3 Clinical Trial at 47th Annual NCDEU Meeting (Business Wire via Yahoo! Finance) http://www.treatanxietydisorder.com/PanicAttack/103/anxiety-disorder-news-epix-pharmaceuticals-presents-findings-from-prx-00023-phase-3-clinical-trial-at-47th-annual-ncdeu-meeting-business-wire-via-yahoo-finance/ Premium Resource For Treating Anxiety Disorder Wed, 19 Nov 2008 13:59:10 +0000 http://wordpress.org/?v=2.0.7